Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Axios
Axios
Health

FDA wants heartburn drug Zantac pulled from market

The Food and Drug Administration is asking all makers of ranitidine, a heartburn drug most commonly known by the brand name Zantac, to pull all forms of the medicine from the market.

The bottom line: Don't take any versions of this drug, which has been linked to cancer-causing contaminants.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.